Resting the Pancreas in Cystic Fibrosis

• Research type

  Research Study

• Full title

  PRESERVING ?ETA-CELLS: 'RESTING THE PANCREAS’ IN CYSTIC FIBROSIS

• IRAS ID

  105249

• Contact name

  Martin Walshaw

• Sponsor organisation

  Liverpool Heart and Chest Hospital

• Eudract number

  2012-002880-86

• Research summary

  The study involves adult patients with Cystic fibrosis, who are known to have impaired glucose tolerance and hyperglycaemia due to insulin deficiency caused by progressive pancreatic destruction, the pathognomonic feature in this condition. We intend to administer Insulin (Levemir) to these individuals and study their physiological (pancreatic) responses to it after a 2 week period. Insulin is an indicated treatment for hyperglycaemia.

• REC name

  Yorkshire & The Humber - Sheffield Research Ethics Committee

• REC reference

  13/YH/0007

• Date of REC Opinion

  25 Jan 2013

• REC opinion

  Further Information Favourable Opinion